Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Access of high technology medi...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Access of high technology medicines in Russia

Bibliographic Details
Published in:Journal of Pharmaceutical Policy and Practice
Main Authors: Liudmila Bezmelnitsyna, Dmitry Meshkov, Ramil Khabriev
Format: Article
Language:English
Published: Taylor & Francis Group 2015-12-01
Subjects:
Infliximab
Etanercept
Juvenile Idiopathic Arthritis
Adalimumab
Health Technology Assessment
Online Access:https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P19
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P19

Similar Items

  • Choice and switch of biologic drugs in juvenile idiopathic arthritis
    by: Seher Şener, et al.
    Published: (2023-12-01)
  • Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
    by: Bruna O. Ascef, et al.
    Published: (2021-07-01)
  • Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
    by: Mariam R Fadel, et al.
    Published: (2024-10-01)
  • THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
    by: Dmitry Evgenyevich Karateyev
    Published: (2009-09-01)
  • HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE
    by: A. S. Kolbin, et al.
    Published: (2016-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs